Net profit of Novartis India rose 18.67% to Rs 24.22 crore in the quarter ended September 2025 as against Rs 20.41 crore during the previous quarter ended September 2024. Sales rose 3.71% to Rs 90.33 crore in the quarter ended September 2025 as against Rs 87.10 crore during the previous quarter ended September 2024.
| Particulars | Quarter Ended |
| Sep. 2025 | Sep. 2024 | % Var. |
| Sales | 90.33 | 87.10 | 4 |
| OPM % | 26.44 | 20.62 | - |
| PBDT | 33.17 | 28.14 | 18 |
| PBT | 32.65 | 27.56 | 18 |
| NP | 24.22 | 20.41 | 19 |